Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
|---|---|
| pe ratio | -4.91 |
| peg ratio | 1.90 |
| price to book ratio | 5.81 |
| price to sales ratio | 5.19 |
| enterprise value multiple | -5.84 |
| price fair value | 5.81 |
profitability ratios | |
|---|---|
| gross profit margin | -58.77% |
| operating profit margin | -114.19% |
| pretax profit margin | -100.78% |
| net profit margin | -100.78% |
| return on assets | -22.48% |
| return on equity | -84.39% |
| return on capital employed | -34.06% |
liquidity ratio | |
|---|---|
| current ratio | 2.92 |
| quick ratio | 2.92 |
| cash ratio | 1.83 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 4.25 |
| days of payables outstanding | 59.54 |
| cash conversion cycle | -55.30 |
| receivables turnover | 85.97 |
| payables turnover | 6.13 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.23 |
| debt equity ratio | 1.23 |
| long term debt to capitalization | 0.48 |
| total debt to capitalization | 0.55 |
| interest coverage | -10.65 |
| cash flow to debt ratio | -0.51 |
cash flow ratios | |
|---|---|
| free cash flow per share | -0.23 |
| cash per share | 1.15 |
| operating cash flow per share | -0.23 |
| free cash flow operating cash flow ratio | 1.02 |
| cash flow coverage ratios | -0.51 |
| short term coverage ratios | -2.12 |
| capital expenditure coverage ratio | -55.56 |
Frequently Asked Questions
Innate Pharma S.A. (IPHA) published its most recent earnings results on 12-09-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Innate Pharma S.A. (NASDAQ:IPHA)'s trailing twelve months ROE is -84.39%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Innate Pharma S.A. (IPHA) currently has a ROA of -22.48%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
IPHA reported a profit margin of -100.78% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 2.92 in the most recent quarter. The quick ratio stood at 2.92, with a Debt/Eq ratio of 1.23.